CytoDyn Inc. CYDY
OTC PK
| 08/31/2026 | 05/31/2026 | 02/28/2026 | 11/30/2025 | 08/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -171.60% | -1,240.16% | -447.46% | -172.75% | -10.39% |
| Total Depreciation and Amortization | 88.24% | -5.56% | -5.56% | -10.00% | -29.17% |
| Total Amortization of Deferred Charges | -- | -- | -87.53% | -82.67% | -72.00% |
| Total Other Non-Cash Items | 1,510.26% | 9.92% | -72.91% | -93.30% | -94.60% |
| Change in Net Operating Assets | 412.02% | 235.25% | 266.28% | 352.83% | 145.93% |
| Cash from Operations | -35.26% | -96.83% | -278.41% | -717.41% | -1,490.74% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 100.00% | 80.00% | 80.00% | 80.00% | 80.00% |
| Issuance of Common Stock | 2,274.25% | 1,287.45% | 376.75% | -80.26% | -81.59% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -91.58% | -91.58% | -100.00% | -100.00% |
| Cash from Financing | 2,672.51% | 58.48% | 31.29% | -93.63% | -93.87% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 145.08% | -102.44% | -108.89% | -211.92% | -195.35% |